Log In
BCIQ
Print this Print this
 

amcasertib (BB503, BBI503)

  Manage Alerts
Collapse Summary General Information
Company Sumitomo Dainippon Pharma Co. Ltd.
DescriptionSmall molecule multi-kinase inhibitor of nanog homeobox (NANOG) and other cancer stem cell pathways
Molecular Target Nanog homeobox (NANOG)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I/II
Standard IndicationSolid tumors
Indication DetailsTreat advanced solid tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$2,640.0M

$200.0M

$2,440.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

04/24/2012

$2,640.0M

$200.0M

$2,440.0M

Get a free BioCentury trial today